Previous studies have shown that GCKR variation is associated with both elevated TG and reduced fasting glucose and T2D risk, [7,8] potentially implicating its role in hepatic de-novo lipogenesis [9], through which it would promote glucose uptake, glycolysis, and subsequently increase plasma TG levels [10]. Here, GCKR is linked to type 2 diabetes mellitus.